The European Union’s top diplomat Josep Borrell said on Friday (February 5) that he hoped the European Medicines Agency (EMA) could authorize the use of the Russian Sputnik V coronavirus vaccine in the European Union.
European scientists gave Russia’s Sputnik V vaccine the green light on Tuesday (February 2), saying it was almost 92% effective in fighting COVID-19 based on peer-reviewed, late-stage trial results published in The Lancet international medical journal.
The Sputnik V vaccine is the fourth worldwide to have Phase III results published in leading peer-reviewed medical journals following the shots developed by Pfizer and BioNTech, Moderna and AstraZeneca.
(Reuters)
